Starbucks Corp. sell BiotechBee
Start price
22.09.22
/
60%
€86.57
Target price
31.12.24
€75.00
Performance (%)
5.46%
End price
21.12.22
€91.30
Summary
This prediction ended on 21.12.22 with a price of €91.30. The SELL prediction by BiotechBee shows the price for Starbucks Corp. slightly increased by 5.46% during the runtime of the prediction. A total of €0.53 was paid as dividends for this prediction. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Starbucks Corp. | 1.758% | 1.758% | -2.031% | -6.040% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
According to BiotechBee what are the pros and cons of Starbucks Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by BiotechBee for this prediction
In the thread Starbucks Corp. diskutieren
Sell mit Kursziel 75,0